Longevity
Rapalogix raises $20m for longevity skin health
Series A funding will expand Re-Q and advance a pipeline built on mTOR biology as longevity science seeks commercial traction. Rapalogix Health has raised $20 million in Series A financing to support the expansion of its longevity-focused skin health platform, as investors continue to back companies attempting to translate aging biology into products with clear […] The post Rapalogix raises $20m for longevity skin health appeared first on Longevity.Technology .
This story was reported by Longevity.Technology. EUROPES curates Europe's most relevant coverage — read the full report at the original source.
Read full coverage at Longevity.Technology →